Viral hepatitis B, C and HIV infection in Croatian prisons
- PMID: 20202285
- DOI: 10.1017/S0950268810000476
Viral hepatitis B, C and HIV infection in Croatian prisons
Abstract
Incarcerated persons comprise about 0.4% of the Croatian population, of whom 25-30% misuse drugs. We attempted to determine the structure of the prison population, prevalence of HBV, HCV, HIV markers, co-infections with HBV, HCV and HIV and acute HBV, HCV and HIV infection. In total, 25.9% of prisoners were positive for some markers for viral hepatitis (HBV 11.3%, HCV 8.3%, HBV/HCV 6.3%). Prevalence of HBV infection in intravenous drug users (IDUs) was 26.2% (highly promiscuous group 20.4%, individuals with psychiatric diseases and personality disorders 16.0%). HCV infection in IDUs was 52.0% and 4.9% in the highly promiscuous group. HBV/HCV co-infection was registered in 34.9% of prisoners positive for HBV markers (203/582). Acute HBV infection was detected in 0.5%, and HCV in 1.2%. Only 0.15% (5/3348) of prisoners were anti-HIV positive. It appears that individuals with psychiatric diseases and personality disorders could be an additional risk population for these viral infections.
Similar articles
-
[Prevalence of hepatitis B and C among prison population in Croatia].Acta Med Croatica. 2009 Dec;63(5):447-50. Acta Med Croatica. 2009. PMID: 20198906 Croatian.
-
Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.J Med Virol. 2005 Jul;76(3):311-7. doi: 10.1002/jmv.20375. J Med Virol. 2005. PMID: 15902712
-
Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.Trop Gastroenterol. 2007 Jan-Mar;28(1):19-23. Trop Gastroenterol. 2007. PMID: 17896605
-
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.Lancet. 2016 Sep 10;388(10049):1089-1102. doi: 10.1016/S0140-6736(16)30466-4. Epub 2016 Jul 14. Lancet. 2016. PMID: 27427453 Review.
-
Tuberculosis and HIV in people who inject drugs: evidence for action for tuberculosis, HIV, prison and harm reduction services.Curr Opin HIV AIDS. 2012 Jul;7(4):345-53. doi: 10.1097/COH.0b013e328354bd44. Curr Opin HIV AIDS. 2012. PMID: 22678489 Review.
Cited by
-
Prevalence of HIV and Hepatitis B, C, D Infections and Their Associated Risk Factors among Prisoners in Southern Khorasan Province, Iran.Iran J Public Health. 2014 Feb;43(2):229-34. Iran J Public Health. 2014. PMID: 26060747 Free PMC article.
-
Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.BMC Infect Dis. 2018 Feb 12;18(1):79. doi: 10.1186/s12879-018-2988-x. BMC Infect Dis. 2018. PMID: 29433454 Free PMC article.
-
Personality dysfunction in opiate addicts on opioid substitution treatment and the risk of HCV infection.Front Public Health. 2022 Sep 9;10:1009413. doi: 10.3389/fpubh.2022.1009413. eCollection 2022. Front Public Health. 2022. PMID: 36159261 Free PMC article.
-
Seroprevalence Trends and Molecular Epidemiology of Viral Hepatitis in Croatia.Life (Basel). 2023 Jan 13;13(1):224. doi: 10.3390/life13010224. Life (Basel). 2023. PMID: 36676173 Free PMC article. Review.
-
Substance Use During Imprisonment in Low- and Middle-Income Countries.Epidemiol Rev. 2018 Jun 1;40(1):70-81. doi: 10.1093/epirev/mxx016. Epidemiol Rev. 2018. PMID: 29584860 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical